https://www.thebodypro.com/category/hiv-care-continuum/tag/women

The Latest

pulling back curtain

This Week in HIV Research: Life in the Integrase Era

Aug. 6, 2020: Recent trends in drug interaction rates; integrase inhibitors and cardiac event risk; a deep dive into HIV drug resistance in Florida; frailty symptoms and neurocognitive disorders amidst high CD4 counts.

By Barbara Jungwirth and Myles Helfand
solving maze

This Week in HIV Research: Solving the Riddle of Poor PrEP Uptake

July 30, 2020: HIV prevention shortfalls among adolescents of color; PrEP use among trans people; PrEP information gaps among women of color; the case for vacation-based (a.k.a. episodic) PrEP.

By Barbara Jungwirth and Myles Helfand
links in chain

This Week in HIV Research: Links in a Chain

July 16, 2020: Starting HIV treatment during hospitalization for people who use drugs; type of substance use affects viral suppression odds; benefits of a cross-disciplinary medical support team; does STI recency dictate PrEP necessity for women?

By Barbara Jungwirth and Myles Helfand
cisgender woman prescription

Evaluating PrEP Uptake and Adherence in Cisgender Women—and What to Do About It

Two researchers discuss their analysis of Philadelphia FIGHT’s HIV pre-exposure prophylaxis (PrEP) program for cisgender women.

By Terri Wilder, M.S.W.
minority stress theory

Why All HIV Care Must Be Trauma-Informed Care

Giving good HIV care means taking into account the many marginalize identities patients can hold. And, being marginalized often comes with a lot of trauma.

By Chase Alston
beat goes on

This Week in HIV Research: The Beat Goes On

March 19, 2020: Mood disorders and metabolic syndrome; comorbidity burden among women living with HIV; two-year weight gain after switching to integrase; long-term adipose tissue density trends.

By Barbara Jungwirth and Myles Helfand
men on beach

This Week in HIV Research: Do You Believe in U=U?

Feb. 27, 2020: U=U perception vs. reality; frequency of incorrect self-reported viral load levels; how HIV transmission cluster predicts care continuum gaps; integrase inhibitor uptake and discontinuation.

By Barbara Jungwirth and Myles Helfand
close up of cannabis plant

This Week in HIV Research: More Answers—and Questions—on Cannabis Use

Jan. 23, 2020: Neurocognitive benefits of cannabis use; how unquantifiable HIV in CSF correlates to executive function; updated findings on efavirenz and microcephaly; cost-efficacy of a specialized HIV care coordination team.

By Barbara Jungwirth and Myles Helfand
woman's hand using phone

This Week in HIV Research: Just a Text Away

Jan. 16, 2020: Texting (and stigma support) vs. email for care retention; beyond-childhood health risks for HIV-exposed infants; HIV, cardiovascular risk, and cognitive impairment; direct-acting antiviral efficacy and prescription delays.

By Barbara Jungwirth and Myles Helfand
hand reaching

This Week in HIV Research: Where Our Reach Falls Short

Dec. 19, 2019: Often-insufficient CD4 and viral load testing for women; factors affecting syphilis incidence among women with HIV; STI testing rates among people with HIV; the effect of benzodiazepines on neurocognition.

By Barbara Jungwirth and Myles Helfand